EndoVE endosCopic Treatment for Oesophageal and Gastric canceR

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 13, 2021

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions
Oesophageal CancerOesophageal DiseaseGastric Cancer
Interventions
PROCEDURE

EndoVE

On the day of the procedure, a review of any changes which occurred since the pre-study visit will be conducted. The patient will be placed under general anaesthesia or sedated before Bleomycin will be delivered intravenously. The patient will then be treated endoscopically with the EndoVE device. The EndoVE procedure should take no longer than 30 minutes.

Trial Locations (1)

Unknown

Nottingham University Hospital, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Nottingham University Hospitals NHS Trust

OTHER

lead

Mirai Medical

INDUSTRY

NCT04649372 - EndoVE endosCopic Treatment for Oesophageal and Gastric canceR | Biotech Hunter | Biotech Hunter